Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Debt / NOTE 0.750% 5/1
-
Number of holders
-
48
-
Total 13F principal, excl. options
-
336,008,737
-
Principal change
-
-138,700,737
-
Total reported value, excl. options
-
$348,627,573
-
Value change
-
-$134,181,176
-
Number of buys
-
29
-
Number of sells
-
-28
-
Price
-
$1.04
Significant Holders of LIGAND PHARMACEUTICALS INC - NOTE 0.750% 5/1 as of Q1 2021
62 filings reported holding 53220KAF5 - LIGAND PHARMACEUTICALS INC - NOTE 0.750% 5/1 as of Q1 2021.
LIGAND PHARMACEUTICALS INC - NOTE 0.750% 5/1 has 48 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $336,008,737 of principal
.
Largest 10 bondholders include ADVENT CAPITAL MANAGEMENT /DE/ ($50,581,000 of principal), CANYON CAPITAL ADVISORS LLC ($47,500,000 of principal), LAZARD ASSET MANAGEMENT LLC ($39,000,000 of principal), WOLVERINE ASSET MANAGEMENT LLC ($34,938,000 of principal), WESTWOOD HOLDINGS GROUP INC. ($23,500,000 of principal), D. E. Shaw & Co., Inc. ($18,540,000 of principal), OAKTREE CAPITAL MANAGEMENT LP ($15,259,000 of principal), Davidson Kempner Capital Management LP ($12,500,000 of principal), Polygon Management Ltd. ($12,000,000 of principal), and STATE STREET CORP ($11,772,000 of principal).
This table shows the top 48 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.